AMEX · NNVC

NanoViricides Inc.

$1.48 -$0.05 (-3.27%) 1D After hours
Session Pulse Overnight session chatter is way louder than usual 4 mentions today No new SEC filings since Mon close its sector ranked 6/11 this week Full pulse →

Key Metrics

$35.16M
Market cap
P/E · TTM
Revenue · TTM
−$8.09M
Net income
EPS · TTM $-0.41
Dividend yield
Free cash flow −$7.37M
Beta · 1Y 1.91
EBITDA · TTM −$7.50M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Offering paper hit the record (Form 424B5).

    424B5 - NANOVIRICIDES, INC. (0001379006) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 27
    Offering paper hit the record (Form 424B5).

    424B5 - NANOVIRICIDES, INC. (0001379006) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 27
    2 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 2, TIMESTAMPED
  • Jul 27
    Chatter ran way louder than usual.

    4 mentions across the stream that day (+7.9σ vs its own baseline) — attention, not direction. Loud days mark where the crowd was looking.

    RECEIPT: NARRATIVE VELOCITY, 30-DAY BASELINE
  • Jul 17
    A material event was filed (Form 8-K).

    8-K - NANOVIRICIDES, INC. (0001379006) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 12
    From its May 28 high, the share price fell 34%.

    Peak close $1.86 on May 28; trough close $1.22 on Jun 12. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Apr 17
    The stock moved +18.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$35.16M
Enterprise value
Shares outstanding23.0M
52-wk range$0.85 – $2.23
Avg volume · 20D431.9K
Net cash
Book value / share$0.47
IndustryPharmaceutical Preparations
ExchangeAMEX
About NanoViricides Inc.
IPO dateJul 5, 2005
Employees7

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -78.5% · —

Financial Health

Current ratio3.17
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$2.31M

Cash Flow · TTM

Operating CF −$7.28M
Capex −$94.52K
Free cash flow −$7.37M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings